OMCL vs. FIT, MDRX, HSTM, HMI, CRTX, OSS, ZEPP, SCKT, CERN, and AAPL
Should you be buying Omnicell stock or one of its competitors? The main competitors of Omnicell include Fitbit (FIT), Veradigm (MDRX), HealthStream (HSTM), Huami (HMI), Cortexyme (CRTX), One Stop Systems (OSS), Zepp Health (ZEPP), Socket Mobile (SCKT), Cerner (CERN), and Apple (AAPL).
Fitbit (NYSE:FIT) and Omnicell (NASDAQ:OMCL) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking, media sentiment and valuation.
97.7% of Omnicell shares are held by institutional investors. 18.6% of Fitbit shares are held by company insiders. Comparatively, 2.6% of Omnicell shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
In the previous week, Fitbit had 8 more articles in the media than Omnicell. MarketBeat recorded 12 mentions for Fitbit and 4 mentions for Omnicell. Fitbit's average media sentiment score of 1.46 beat Omnicell's score of 0.00 indicating that Omnicell is being referred to more favorably in the news media.
Fitbit received 298 more outperform votes than Omnicell when rated by MarketBeat users. However, 67.82% of users gave Omnicell an outperform vote while only 66.75% of users gave Fitbit an outperform vote.
Omnicell has lower revenue, but higher earnings than Fitbit. Omnicell is trading at a lower price-to-earnings ratio than Fitbit, indicating that it is currently the more affordable of the two stocks.
Fitbit has a net margin of 0.00% compared to Fitbit's net margin of -1.91%. Fitbit's return on equity of 2.41% beat Omnicell's return on equity.
Omnicell has a consensus target price of $42.20, suggesting a potential upside of 29.49%. Given Fitbit's higher probable upside, analysts plainly believe Omnicell is more favorable than Fitbit.
Summary
Omnicell beats Fitbit on 10 of the 16 factors compared between the two stocks.
Get Omnicell News Delivered to You Automatically
Sign up to receive the latest news and ratings for OMCL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OMCL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Omnicell Competitors List
Related Companies and Tools
